Aug 13 (Reuters)-
Haba Laboratories Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2024 Jun 30, 2023 Mar 31, 2025
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 2.67 2.57 12.65
(+3.9 pct) (-7.8 pct) (+2.6 pct)
Operating loss 37 mln loss 290 mln 410 mln
Recurring loss 29 mln loss 288 mln 400 mln
Net loss 22 mln loss 215 mln 400 mln
EPS loss 5.88 yen loss 56.87 yen 105.77 yen
Ann Div 40.00 yen 40.00 yen
-Q2 div NIL NIL
-Q4 div 40.00 yen 40.00 yen
NOTE - Haba Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4925.T